Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000823145 | SCV000963992 | uncertain significance | ALG8 congenital disorder of glycosylation | 2021-11-11 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 664953). This variant has not been reported in the literature in individuals affected with ALG8-related conditions. This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 431 of the ALG8 protein (p.Ile431Met). |
Fulgent Genetics, |
RCV002487852 | SCV002791639 | uncertain significance | ALG8 congenital disorder of glycosylation; Polycystic liver disease 3 with or without kidney cysts | 2022-04-20 | criteria provided, single submitter | clinical testing |